Cargando…

Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy

Detalles Bibliográficos
Autor principal: Sadda, Srinivas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608100/
https://www.ncbi.nlm.nih.gov/pubmed/32042181
http://dx.doi.org/10.1038/s41433-020-0802-7
_version_ 1783604771077226496
author Sadda, Srinivas R.
author_facet Sadda, Srinivas R.
author_sort Sadda, Srinivas R.
collection PubMed
description
format Online
Article
Text
id pubmed-7608100
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76081002020-11-05 Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy Sadda, Srinivas R. Eye (Lond) Editorial Nature Publishing Group UK 2020-02-10 2020-09 /pmc/articles/PMC7608100/ /pubmed/32042181 http://dx.doi.org/10.1038/s41433-020-0802-7 Text en © The Royal College of Ophthalmologists 2020
spellingShingle Editorial
Sadda, Srinivas R.
Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
title Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
title_full Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
title_fullStr Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
title_full_unstemmed Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
title_short Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
title_sort lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608100/
https://www.ncbi.nlm.nih.gov/pubmed/32042181
http://dx.doi.org/10.1038/s41433-020-0802-7
work_keys_str_mv AT saddasrinivasr lackofefficacyofeplerenonefortreatmentofactivecentralserouschorioretinopathy